最新の財務諸表(Form-10K)によると、RBC Life Sciences Incの総資産は$15で、純損失は$0です。
RBCLの主要な財務比率は何ですか?
RBC Life Sciences Incの流動比率は2.14、純利益率は0、1株当たり売上高は$12.65です。
RBC Life Sciences Incの収益はセグメントまたは地域別にどのように分けられていますか?
RBC Life Sciences Inc の最大収益セグメントは Leasing and Financing で、最新の利益発表における収益は 49,322,000 です。地域別に見ると、United States が RBC Life Sciences Inc の主要市場であり、収益は 49,322,000 です。
RBC Life Sciences Incは収益を上げていますか?
いいえ、最新の財務諸表によると、RBC Life Sciences Incの純損失は$0です。
RBC Life Sciences Incに負債はありますか?
はい、RBC Life Sciences Incの負債は7です。
RBC Life Sciences Incの発行済株式数は何株ですか?
RBC Life Sciences Incの総発行済株式数は2.21株です。
主要データ
前終値
$0.0007
始値
$0.0002
当日レンジ
$0.0002 - $0.0007
52週レンジ
$0.0001 - $0.0007
取引高
2.1K
平均取引高
160
配当利回り
--
1株当たり利益(TTM)
-0.25
時価総額
$1.5K
RBCLとは何ですか?
RBC Life Sciences, Inc. engages in the marketing and distribution of nutritional supplements and personal care products. The company is headquartered in Irving, Texas. The firm's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.